This bill creates a Cannabis Production Establishment and Pharmacy Licensing Advisory Board to oversee medical cannabis pharmacy licensing in Utah. The board, composed of eight to nine members with strict conflict-of-interest rules (e.g., no industry ties), reviews license applications and location changes. Key provisions require the board to consider geographic access, patient cost efficiency, and medical cannabis availability when approving pharmacy location shifts. It directly affects medical cannabis pharmacies seeking new locations or operational changes, ensuring decisions align with public health and geographic distribution goals. The bill amends Utah code sections governing licensing procedures but does not appropriate funds or change patient eligibility.
SB 121 amends Utah's medical cannabis program to clarify rules and improve accessibility for patients and providers. Key changes include allowing legal guardians to obtain medical cannabis cards for incapacitated adults, creating a voucher program for patients to access cannabis or devices, and updating transportation and safe storage requirements for deliveries. The bill also streamlines administrative processes, such as revising how providers access patient information and simplifying identification requirements for cardholders. These changes affect medical cannabis patients, licensed providers, and delivery services operating under Utah's current program.
HB 416 creates the Firefighter Cancer Benefit Trust Fund to provide financial support for firefighters diagnosed with cancer presumed to be work-related. The bill redirects existing revenue from property and life insurance premiums (specifically 50% of the first $4 million from property insurance tax and 10% of the first $1 million from life insurance tax) to fund this trust, replacing prior allocations. The trust fund, administered by an 11-member board (including firefighters, fire chiefs, medical experts, and officials), will cover benefits for affected firefighters and their families, with assets protected from creditor claims. This bill modifies tax distribution rules without new appropriations, directly affecting Utah firefighters with presumptive cancer diagnoses under existing law.
HB 269 amends Utah's ambulance payment rules to directly affect ambulance providers and health insurers or workers' compensation carriers. It requires the Bureau of Emergency Medical Services to annually adjust base rates based on medical inflation, explicitly includes medication costs in the base rate (previously excluded), and allows providers to collect both base rates and mileage fees. The bill also clarifies that health plans must pay providers directly for covered ambulance services without balance billing for uncovered portions. These changes take effect January 1, 2027, with no new state funding required.
HB 122 requires Utah correctional facilities to report the number of pregnant inmates and inmates who are parents of minor children. It extends postpartum recovery care to 12 weeks, prohibits restraints during this period without specific security justification, and increases social worker access from six to 12 weeks to help inmates arrange childcare, plan family reunification, and access substance abuse treatment if needed. The bill also clarifies that facilities must provide postpartum medical care for 12 weeks after childbirth. These changes directly affect pregnant and postpartum incarcerated individuals in Utah state prisons and county jails.
This concurrent resolution directs Utah's Public Employees' Benefit and Insurance Program (PEHP) to add hormone replacement therapy (HRT) treatments for perimenopausal and menopausal symptoms to its drug formulary. It specifically affects state employees covered by PEHP health plans, requiring the program to include these treatments in its approved medications. The resolution does not address "black box" warnings but mandates PEHP to cover HRT for symptom relief. As a procedural directive, it guides an agency's existing policy without creating new law.
HB 599 amends Utah's social services funding to redirect interest earned from the Medicaid ACA Fund into the General Fund, freeing up $759,700 annually for 2026-2027. It adds immunosuppressive drugs to Medicaid's preferred drug list and transitions the Children's Health Insurance Program (CHIP) into Medicaid, with dental services for CHIP beneficiaries to be provided through the University of Utah School of Dentistry. The bill also allocates funds from electronic cigarette taxes to support substance use treatment and prevention services. These changes directly affect Medicaid beneficiaries, CHIP enrollees (now covered under Medicaid), and individuals seeking substance use treatment.
HB 389 amends Utah's medical cannabis laws to simplify licensing for processors, allowing them to make cannabinoid (hemp) products without an extra license. It creates a new fee on medical cannabis purchases for enforcement, moves oversight of the medical cannabis program to the Department of Agriculture and Food, and allows low-THC products (under 0.3% THC) to be sold by pharmacies. The bill also enables patients to get medical cannabis cards via virtual doctor visits and renames the licensing board to the Specialized Product Authority Licensing Board. These changes directly affect medical cannabis processors, pharmacies, patients, and state agencies managing the program.
SB 98 creates a voluntary certification program for employers to become "recovery ready workplaces," administered by Utah's Department of Health and Human Services. Employers seeking certification must implement specific practices, including preventing workplace factors that contribute to substance use disorders, reducing stigma, providing employee education, making naloxone (an opiate antagonist) available, and supporting employees accessing treatment. The bill authorizes the department to establish application criteria and an application process, with potential funding from the Electronic Cigarette Substance and Nicotine Product Proceeds Restricted Account. This program directly affects employers who choose to participate, aiming to improve workplace support for employees with substance use disorders.
This bill directs Utah's Public Employees' Benefit Insurance Program (PEHP) to create a new "Weight Management and Obesity Pilot Program" starting in 2026. It combines PEHP's existing bariatric surgery pilot with an alternative option for covered state employees to receive GLP-1 drugs (like Ozempic) instead of surgery, while staying within the existing $1.05 million annual budget. Key provisions include requiring 50% member cost-sharing, capping monthly pharmacy expenses at $300, limiting coverage to 24 months, and applying the same health coaching requirements to both options. The program allows eligible members (with BMI over 40 or 35+ with health conditions) to choose once between surgery or GLP-1 treatment, with annual reports to lawmakers.